Mexiletine and Propranolol Interaction

Drug interaction information between Mexiletine and Propranolol.

Mexiletine and Propranolol have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Mexiletine and Propranolol. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Mexiletine

Class IB Antiarrhythmic

Drug B

Propranolol

Non-Selective Beta-Blocker

How They Interact

These two heart medicines can be used together to help control irregular heartbeats without changing the heart's electrical timing.

FDA Label Information

A variety of antiarrhythmics such as quinidine or propranolol were also added, sometimes with improved control of ventricular ectopy. ECG intervals (PR, QRS, and QT) were not affected by concurrent mexiletine and digoxin, diuretics, or propranolol.

Frequently Asked Questions

What SPL severity band is on file for Mexiletine + Propranolol?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Propranolol has 44 labeled pairs on file vs Mexiletine's 14. In the minor band specifically: Mexiletine has 13 (also Digoxin, Propafenone, Theophylline, Cimetidine); Propranolol has 44 (also Clonidine, Diltiazem, Warfarin, Verapamil).

What mechanism field is on file for Mexiletine and Propranolol?

These two heart medicines can be used together to help control irregular heartbeats without changing the heart's electrical timing.

Propranolol's labeled portfolio outnumbers Mexiletine

SPL source-record counts only. This page's band is minor · classes on file: Mexiletine (Class IB Antiarrhythmic); Propranolol (Non-Selective Beta-Blocker).

Mexiletine

0 major · 1 moderate · 13 minor · 14 total

Propranolol

0 major · 0 moderate · 44 minor · 44 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.